Enabling Drug Discovery Targeting Ion Channels

At another stop on the Road to 50 States, Douglas Krafte, Senior Vice President at Icagen, talks to Nigel about the Icagen's new location Icagen resulting in a total of almost 30,000 square feet in lab space.

Doug Krafte, Ph.D.

Doug Krafte is currently the Chief Scientific Officer at Icagen, Inc. Dr. Krafte has held a variety of positions over 25 years within the pharma / biotech sectors across multiple therapeutic areas, most recently as Executive Director & Site Head for the US arm of Pfizer’s Pain & Sensory Disorders Research Unit, as well as positions at Aurora Biosciences, Boehringer Ingelheim and Sterling Winthrop.